EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fisetin promotes skin wound healing and inhibits pathological scar formation through modulation of the PI3K/Akt/TGF-β1 signaling axis

Fisetin fördert die Heilung von Hautwunden und hemmt pathologische Narbenbildung durch Modulation der PI3K/Akt/TGF-β1-Signalkaskade

Yi Han, Guixin Sun

Frontiers in Pharmacology · 27.03.2026 · 17

DOI: 10.3389/fphar.2026.1793847 ↗

Auf einen Blick

In einer Ratten- und Zellstudie beschleunigte Fisetin die Wundheilung und verringerte die Narbenbildung. Die Effekte waren mit weniger Entzündung und veränderter Kollagenremodellierung verbunden.

Fragestellung

Welche Wirkung hat Fisetin auf die Hautwundheilung und die Hemmung von Narbenbildung?

Methode

Netzwerkpharmakologie, molekulares Docking, Full-thickness-Hautwundmodell bei Ratten und in-vitro-Studien mit humanen Dermalfibroblasten.

Ergebnisse

Fisetin beschleunigte den Wundverschluss, verringerte die Infiltration entzündlicher Zellen und verbesserte die histologische Organisation. Es senkte Entzündungswerte, das Verhältnis von COL1A/COL3A und die Expression von TGF-β1 und α-SMA; PTEN stieg.

Schlussfolgerung der Autor:innen

Fisetin fördert die Hautwundheilung und vermindert proliferative Narbenbildung durch weniger Entzündung, bessere Kollagenremodellierung und Hemmung fibrotischer Signalwege.

Kernaussagen

  • Schnellerer Wundverschluss im Rattenmodell
  • Weniger Entzündung und geringere Narbenbildung
  • PI3K/Akt/TGF-β1-Achse und PTEN betroffen

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.03.2026. Verfasst von Yi Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fudan University.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

During the healing of skin wounds, excessive fibrosis and collagen remodeling disorders often lead to the formation of proliferative scars. Fisetin is a naturally occurring flavonoid compound with antioxidant and anti-fibrotic properties. However, its therapeutic effect and mechanism of action in wound healing and inhibition of scar formation are still unknown.

Methods

This study used network pharmacological methods to identify potential targets and pathways related to wound healing and proliferative scar formation. Through protein-protein interaction analysis, Gene Ontology analysis and enrichment analysis of the Kyoto Encyclopedia of Genes and Genomes (KEGG), its potential biological functions were clarified. In addition, molecular docking was also carried out to evaluate the binding affinity between fisetin and the core target. The effect of fisetin on wound closure and collagen deposition was evaluated using the full-thickness skin wound model in rats. In in vitro experiments, human dermal fibroblasts were used to study the effect of fisetin on collagen expression and the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway.

Results

Network pharmacological analysis highlighted serine/threonine kinase 1 (AKT1) as a central target linking fisetin to wound repair and fibrosis. Functional enrichment indicated significant involvement of the PI3K/Akt pathway. Molecular docking further confirmed a strong binding affinity between fisetin and AKT1. In vivo experiments demonstrated that fisetin significantly accelerated wound closure, reduced inflammatory cell infiltration, and improved histological organization. Quantitative analysis showed decreased histological inflammation scores and a reduced the ratio of type I collagen (COL1A)/type III collagen (COL3A), indicating improved collagen remodeling and attenuated scar formation. Moreover, fisetin upregulated PTEN expression while suppressing transforming growth factor-beta1 (TGF-β1) and alpha-smooth muscle actin (α-SMA) expression in wound tissues. In vitro experiments further confirmed that fisetin inhibited profibrotic marker expression and regulated PI3K/Akt signaling activity in HDFs.

Conclusion

Fisetin promotes skin wound healing and attenuates proliferative scar formation by reducing inflammation, improving collagen remodeling, and suppressing fibrotic signaling. Mechanistically, fisetin upregulates PTEN and inhibits the PI3K/Akt/TGF-β1 axis, thereby limiting fibroblast activation and pathological extracellular matrix deposition. These findings suggest fisetin as a promising therapeutic candidate for wound management and scar prevention.

Schlagwörter

Stichwörter der Autor:innen

collagen remodelingfisetinhypertrophic scarnetwork pharmacologywound healing

Autor:innen und Institutionen

  • Department of Traumatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Traumatic Orthopedics and Joint, People's Hospital of Guangming District, Shenzhen, Guangdong, China.

Förderung

  • Fudan University

Zitieren

APA

Han, Y., & Sun, G. (2026). Fisetin promotes skin wound healing and inhibits pathological scar formation through modulation of the PI3K/Akt/TGF-β1 signaling axis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1793847

Vancouver

Han Y, Sun G. Fisetin promotes skin wound healing and inhibits pathological scar formation through modulation of the PI3K/Akt/TGF-β1 signaling axis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1793847

BibTeX
@article{Han2026,
  author = {Han, Yi and Sun, Guixin},
  title = {Fisetin promotes skin wound healing and inhibits pathological scar formation through modulation of the PI3K/Akt/TGF-β1 signaling axis},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1793847}
}
Kostenlos starten →